How is 10x Genomics funded?
10x Genomics's current capital profile is Public company; Nasdaq: TXG.
- Status
- Public company; Nasdaq: TXG
- Funding type
- Public-market financed
- Latest signal
- Use current filings, investor materials, and company news
- Budget signal
- Look for product launches, acquisitions, hiring, capex, and earnings commentary
- Procurement maturity
- Public company operating environment
- Seller angle
- Tie outreach to active initiatives and operating leverage
10x Genomics's funding and ownership milestones
10x Genomics's ownership context is summarized from public-company and official source signals.
- FoundingCompany foundedInitial company formation and market development.
- ScaleOperating scale reachedThe company developed a repeatable customer, product, or distribution base.
- CurrentPublic company; Nasdaq: TXGCurrent listing status as of June 2026.
Sources:10x Genomics official website10x Genomics investor relations or company news
What is 10x Genomics's current ownership status?
10x Genomics's current status is Public company; Nasdaq: TXG. Sellers should verify current listing status and investor materials before using the profile for account planning.
What does 10x Genomics's capital profile mean for sales timing?
A public company with this profile usually has defined budget owners, planning cycles, procurement review, and measurable operating priorities. Outreach should connect to efficiency, growth, security, compliance, retention, margin, or customer experience.
What seller signals matter most?
The most useful signals are leadership changes, acquisitions, geographic expansion, product launches, public guidance, partner programs, capital expenditure plans, and new hiring clusters.
As of June 2026.Sources:10x Genomics official website10x Genomics investor relations or company newsBuiltWith public technology profile
10x Genomics — frequently asked questions
